Skip to main content

Table 2 Neuropathologic findings in the six atypical sCJD cases

From: Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

 

Case

#1

#2

#3

#4

#5

#6

Frontal

SP

++

++/+++

+++

+++/++++

++/+++

++

PrP

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Temporal

SP

++/+++

++/+++

+++

+++

++/+++

++/+++ 

PrP

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Negative

Parietal

SP

++ 

++ 

++/+++ 

+++ 

++ 

++/+++ 

PrP

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Occipital

SP

+++/++++

+++

+++/++++

+++ 

++ 

++/+++ 

PrP

Faint syn, patchy*

Faint syn

Faint syn

Faint syn, patchy*

Faint syn

Faint syn

Striatum

SP

++/+++ 

++ 

++ 

+++ 

 +

 + 

PrP

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Thalamus

SP

 + 

 + 

 + 

 + 

 + 

 + 

PrP

Negative

Faint syn

Faint syn

Faint syn

Negative

Negative

Hippocampus

SP

+

−/+

PrP

Negative

Negative

Negative

Negative

Negative

Negative

Parahippocampus

SP

+++/++++

++/+++

+++/++++

+++/++++

++/+++

++/+++

PrP

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Faint syn

Brainstem

SP

−/+

−/+

−/+

−/+

+/++

PrP

Negative

Negative

Negative

Negative

Plaque-like

Negative

Cerebellum

SP

++

+

++

++

+

+/++

PrP

Syn, patchy*

Syn, patchy*

Syn, patchy*

Syn, patchy*

Syn, patchy*

Syn, patchy*

Balloon neurons

Yes

Yes

Isolated

Yes

Isolated

No

Copathologies

AgD III, ARP: A1,B1,C1 (“possible” PART)

AgD III, ARP: A2,B1,C2

ARP: A1,B1,C1 (“possible” PART), mild CAA

LB limbic, mod-prominent CAA, “definite” PART (Braak II)

ARP: A2,B1,C0, mild CAA

ARP: A2,B1,C0

  1. Scores: −, absent; +, mild; ++, moderate; +++, severe; ++++, status spongiosus. ARP defined according to Montine et al. 2012 [17] (A for amyloid-phase 0–3; B for Braak neurofibrillary stage 0–3; C for CERAD neuritic plaque score 0–3)
  2. SP spongiform change, PrP pattern of prion protein deposition, syn synaptic, AgD argyrophilic grain disease (according to Saito et al. [28], ARP Alzheimer-related pathology, CAA cerebral amyloid angiopathy, LB Lewy body, staging according to Attems et al. [2], PART primary age-related tauopathy (according to Crary et al. [9])
  3. *Focal